- Home
- LYRA vs LIQT Comparison
LYRA vs LIQT Comparison
Compare LYRA & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- LIQT
- Stock Information
- Founded
- LYRA 2005
- LIQT 2004
- Country
- LYRA United States
- LIQT Denmark
- Employees
- LYRA N/A
- LIQT N/A
- Industry
- LYRA Medical/Dental Instruments
- LIQT Industrial Machinery/Components
- Sector
- LYRA Health Care
- LIQT Technology
- Exchange
- LYRA Nasdaq
- LIQT Nasdaq
- Market Cap
- LYRA 15.0M
- LIQT 16.1M
- IPO Year
- LYRA 2020
- LIQT N/A
- Fundamental
- Price
- LYRA $9.15
- LIQT $1.65
- Analyst Decision
- LYRA Buy
- LIQT Strong Buy
- Analyst Count
- LYRA 2
- LIQT 2
- Target Price
- LYRA $16.00
- LIQT $4.80
- AVG Volume (30 Days)
- LYRA 288.0K
- LIQT 29.1K
- Earning Date
- LYRA 08-13-2025
- LIQT 08-13-2025
- Dividend Yield
- LYRA N/A
- LIQT N/A
- EPS Growth
- LYRA N/A
- LIQT N/A
- EPS
- LYRA N/A
- LIQT N/A
- Revenue
- LYRA $1,185,000.00
- LIQT $14,986,815.00
- Revenue This Year
- LYRA N/A
- LIQT $36.89
- Revenue Next Year
- LYRA $1,286.17
- LIQT $16.33
- P/E Ratio
- LYRA N/A
- LIQT N/A
- Revenue Growth
- LYRA N/A
- LIQT N/A
- 52 Week Low
- LYRA $3.81
- LIQT $1.34
- 52 Week High
- LYRA $37.50
- LIQT $3.20
- Technical
- Relative Strength Index (RSI)
- LYRA 44.26
- LIQT 56.05
- Support Level
- LYRA $8.35
- LIQT $1.54
- Resistance Level
- LYRA $9.36
- LIQT $1.86
- Average True Range (ATR)
- LYRA 1.25
- LIQT 0.10
- MACD
- LYRA -0.72
- LIQT 0.01
- Stochastic Oscillator
- LYRA 9.95
- LIQT 48.78
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.